Top Five Articles on GenomeWeb Last Week: Illumina, FDA, Grail, and More

NEW YORK – What were the articles that gained the most interest from GenomeWeb readers last week? Here are the top five:

1. Global Supply Chain Issues Catch up to Illumina, Leading to Delayed NGS Projects
2. FDA Revises SARS-CoV-2 Test Emergency Use Authorization Requirements to Account for Variants
3. Grail Gets NY State Department of Health Approval for Galleri Multicancer Test
4. European Commission Objects to Illumina Pushing Through Grail Purchase, Mulls Response
5. NIH Awards $73M to Continue Buildout of ClinGen